VItamin D in pregnanCy for prevenTion Of eaRlY Childhood Asthma
Recruiting
Phase 3
Interventional Study
Asthma
Respiratory Tract Infections
Gastrointestinal Infection
Croup
Eczema
Allergy
Wheezing
Fractures, Bone
Development, Child
Cognition Disorders in Children
Psychiatric Diagnosis
Pivotal Trial
This treatment is in the last trial phase before FDA approval.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 18 – 45
- Sex
- Female
- Trial phase
- Phase 3
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 2,000 (estimated)
- Sponsor
- Professor Klaus Bønnelykke · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The overall aim of the study is to develop a nutritional preventive vitamin D supplementation strategy in pregnancy for early childhood asthma/persistent wheeze during the first three years of life as we hypothesize that supplementation in higher doses than recommended could reduce the risk of disease development.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
* Pregnant Danish women before week 26 with blood levels of EPA+DHA above 4.7% of total fatty acids
* No current vitamin D intake above the recommended 400 IU/day
* No endocrine-, heart-, kidney- or auto-immune disorders
* No disorders requiring treatment with blood thinning medication
Contacts